Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Green Cross Corporation patents


Recent patent applications related to Green Cross Corporation. Green Cross Corporation is listed as an Agent/Assignee. Note: Green Cross Corporation may have other listings under different names/spellings. We're not affiliated with Green Cross Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Green Cross Corporation-related inventors


Method of treating anemia using long-acting epo formulation

The present invention relates to a method for treating anemia using a long-acting epo formulation, and more specifically, a method for treating patients with anemia by confirmation of safe, long-acting, and optimal effective dosage and usage in administering a fusion polypeptide which comprises an epo and an immunoglobulin hybrid fc to patients with anemia. The method of administering the fusion polypeptide employs an appropriate dosage and usage which not only shows an excellent long-acting property compared to the existing epo products but also minimizes cardiovascular side effects that may occur due to a rapid increase in hemoglobin level, which is an effect of anemia treatment.. ... Green Cross Corporation

Multi-influenza detection kit and method for detecting influenza using the same

The present invention relates to a multi-influenza detection kit comprising monoclonal antibodies and a method of detecting multiple influenza viruses using the kit. More specifically, the present invention relates to a multi-influenza detection kit comprising monoclonal antibodies that bind specifically to influenza type a, type b, subtype h1, subtype h3 and subtype h5, and to a method of detecting influenza viruses using the kit. ... Green Cross Corporation

Methods for preparing hepatitis b immunoglobulin derived from plasma

The present invention relates to a preparation method of a human plasma-derived hepatitis b immunoglobulin preparation. More specifically, the present invention relates to a preparation method of a human plasma-derived hepatitis b immunoglobulin preparation characterized in that plasma protein fraction ii (fraction ii) containing human hepatitis b immunoglobulin is dialysis concentrated and then thrombus-producing materials and impurities formed during processes are removed by anion exchange resin and cation exchange resin purification techniques. ... Green Cross Corporation

Iduronate-2-sulfatase and use thereof

Provided is a modified iduronate-2-sulfatase (ids) gene constructed by inserting the nucleotide of seq id no: 2 into a wild-type ids gene. In addition to being negatively charged, the improved ids enzyme encoded by the modified gene exhibits a sufficient retention time in blood to target the bone, so that it is more effective for treating hunter syndrome.. ... Green Cross Corporation

Pharmaceutical formulation comprising anti-egfr antibody

The present invention provides a pharmaceutical formulation comprising an anti-epidermal growth factor receptor (egfr) antibody. The pharmaceutical formulation has low turbidity, without showing aggregation or particle formation, even under accelerated conditions, and exhibits good stability. ... Green Cross Corporation

Kit for measuring titer of a protein comprising human fc using indirect elisa and method for measuring titer of a protein comprising human fc using the same

Provided are a kit for measuring a titer of a human antibody, a humanized antibody, or a human fc-fusion protein in human plasma or serum, and a method for measuring a titer of a human fc-containing protein in human plasma or serum using the same, and more specifically, a kit for measuring a titer of human fc-containing protein in human plasma or serum, the kit including a diluent for sample, a diluent for conjugate, and a cleansing solution and being used in analysis through an indirect enzyme-linked immunosorbent assay (indirect elisa), and a method for measuring a titer of human fc-containing protein in human plasma or serum using the same.. . ... Green Cross Corporation

Method for purifying immunoglobulin

. . The present invention relates to a method for purifying an immunoglobulin, and more particularly, to a method for purifying an immunoglobulin, which comprises: dialyzing and concentrating an immunoglobulin-containing plasma protein fraction ii paste; removing thrombotic substances from the dialyzed and concentrated fraction by a purification process using ceramic cation exchange resin; and performing elution while maintaining salt concentration at a constant level to maintain the polymer content of the immunoglobulin at a low level. When the immunoglobulin purification method according to the present invention is used, the efficiency with which impurities and thrombotic substances are removed can be increased and the polymer content of the immunoglobulin can be maintained, and thus a stable immunoglobulin with improved quality can be produced.. ... Green Cross Corporation

Method for purifying immunoglobulin

The present invention relates to a method for purifying an immunoglobulin, and more particularly, to a method for purifying an immunoglobulin, which comprises: dissolving immunoglobulin-containing plasma protein fraction i+ii+iii or fraction ii+iii; adding caprylate to the solution to cause precipitation; performing dialysis and concentration after removal of the precipitate; performing anion exchange resin and ceramic cation exchange resin purification processes to effectively remove a solvent and detergent added to inactivate viruses; and performing elution while maintaining salt concentration at a constant level to maintain the immunoglobulin polymer content at a low level. According to the method for preparing the intravenous immunoglobulin according to the present invention, a precipitation step of preparing fraction ii from fraction i+ii+iii or fraction ii+iii as a starting material can be omitted, and problems, including a complicated process and a low yield, which occur in the conventional preparation process employing the polyethylene glycol treatment process, can be solved by use of first sodium caprylate precipitation, anion exchange chromatography and cation exchange chromatography. ... Green Cross Corporation








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Green Cross Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Green Cross Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###